Background Pretreatment drug resistance (PDR) levels to NNRTI approaching 10% have
recently been reported in Mexico. However, subnational differences may exist in PDR …

Background HIV pretreatment drug resistance (PDR) to NNRTIs in persons initiating ART is
increasing in Mexico. Objectives To compare HIV PDR in eight sub-regions of Mexico …

Background Increasing HIV pre-treatment drug resistance (PDR) levels have been observed
in regions with increasing antiretroviral treatment (ART) coverage. However, data is lacking …

Background Transmitted drug resistance (TDR) remains an important concern for the
management of HIV infection, especially in countries that have recently scaled-up …

The recent expansion of antiretroviral treatment (ART) coverage in middle/low-income
countries has been associated with increasing prevalence of HIV pre-ART drug resistance …

In response to increasing pretreatment drug resistance (PDR), Mexico changed its national
antiretroviral treatment (ART) policy, recommending and procuring second-generation …

Background Pretreatment HIV drug resistance (HIVDR) to NNRTIs has consistently
increased in Mexico City during the last decade. Objectives To infer the HIV genetic …

Background Pre-treatment HIV drug resistance (HIVDR) to NNRTIs has consistently
increased in low-/middle-income countries during the last decade. Objectives To estimate …

Introduction We assessed HIV drug resistance (DR) in individuals failing ART (acquired DR,
ADR) and in ART-naïve individuals (pre-ART DR, PDR) in Honduras, after 10 years of …

Background In Argentina, current national guidelines recommend starting with NNRTI-based
regimens. Recently, there have been some local reports regarding concerning levels of …